BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12065865)

  • 1. Vaccination strategies in the treatment of lymphomas.
    Veelken H; Osterroth F
    Oncology; 2002; 62(3):187-200. PubMed ID: 12065865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination strategies for lymphomas.
    Dar MM; Kwak LW
    Curr Oncol Rep; 2003 Sep; 5(5):380-6. PubMed ID: 12895388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
    Ruffini PA; Di Nicola M; Carlo-Stella C; Siena S; Gianni AM
    Curr Gene Ther; 2005 Oct; 5(5):511-21. PubMed ID: 16250891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
    Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H
    Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active immunotherapy in follicular lymphoma.
    Veelken H
    Semin Cancer Biol; 2003 Jun; 13(3):241-7. PubMed ID: 12959355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
    Hurvitz SA; Timmerman JM
    Curr Opin Oncol; 2005 Sep; 17(5):432-40. PubMed ID: 16093791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I; Qin H; Kwak LW
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
    Bertinetti C; Simon F; Zirlik K; Heining-Mikesch K; Pfeifer D; Osterroth F; Rosenthal FM; Veelken H
    Eur J Haematol; 2006 Nov; 77(5):395-402. PubMed ID: 16879605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R; Levy R
    Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
    Ashour AK; Petersen JL; McIlhaney MM; Vose JM; Solheim JC
    Hybridoma (Larchmt); 2006 Oct; 25(5):306-8. PubMed ID: 17044787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination strategies in follicular lymphoma.
    Kannan S; Neelapu SS
    Curr Hematol Malig Rep; 2009 Oct; 4(4):189-95. PubMed ID: 20425407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
    Timmerman JM
    Adv Pharmacol; 2004; 51():271-93. PubMed ID: 15464914
    [No Abstract]   [Full Text] [Related]  

  • 15. [Past, present and future of anti-idiotype vaccination].
    Rodríguez Calvillo M; Inogés S; López Díaz de Cerio A; Zabalegui N; Panizo C; Hernández M; Pérez Calvo J; Prósper F; Melero I; Sánchez-Ibarrola A; Rocha E; Bendandi M
    Rev Med Univ Navarra; 2004; 48(3):14-23. PubMed ID: 15622921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic idiotype vaccines in B lymphoproliferative diseases.
    Coscia M; Kwak LW
    Expert Opin Biol Ther; 2004 Jun; 4(6):959-63. PubMed ID: 15174977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human idiotype-specific T cells in lymphoma and myeloma.
    Weng J; Neelapu SS; Woo AF; Kwak LW
    Curr Top Microbiol Immunol; 2011; 344():193-210. PubMed ID: 20549471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine therapy for B-cell lymphomas: next-generation strategies.
    Neelapu SS; Kwak LW
    Hematology Am Soc Hematol Educ Program; 2007; ():243-9. PubMed ID: 18024636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.
    Leitch HA; Connors JM
    Curr Opin Investig Drugs; 2005 Jun; 6(6):597-604. PubMed ID: 15988911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.
    Koumarianou A; Kountourakis P; Economopoulos T
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):230-2. PubMed ID: 18406604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.